WASHINGTON, DC—Cerebral embolic protection does not reduce clinical or radiographic central nervous system infarctions in patients undergoing surgical aortic valve replacement (AVR), a trial from the ...
WASHINGTON (March 19, 2017) -- Two FDA-cleared medical devices designed to remove potential vessel-blocking debris particles from the bloodstream during aortic valve replacement, known as Embol-X and ...
BERLIN, GERMANY — The full findings of the CLEAN-TAVI trial are now available but will do little to resolve the debate over whether cerebral-protection devices should be routinely used during ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results